As of December 15, 2025, Novo Integrated Sciences Inc (NVOS) reports a Graham Number of 2.22.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Novo Integrated Sciences Inc's Graham Number
Over recent years, Novo Integrated Sciences Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-08-31 | 2.22 |
| 2023-08-31 | 2.22 |
This trend highlights how Novo Integrated Sciences Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Novo Integrated Sciences Inc's Graham Number to Peers
To better understand Novo Integrated Sciences Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Novo Integrated Sciences Inc (NVOS) | 2.22 |
| Cigna Group (CI) | 210.78 |
| Concord Medical Services Holdings Ltd (CCM) | 142.57 |
| Labcorp Holdings Inc (LH) | 140.24 |
| Quest Diagnostics Inc (DGX) | 103.61 |
| CVS Health Corp (CVS) | 69.77 |
Compared to its competitors, Novo Integrated Sciences Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.